| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 345.39B | 316.83B | 276.08B | 252.71B | 226.34B |
| Gross Profit | 76.17B | 64.77B | 60.57B | 54.83B | 48.50B |
| EBITDA | 69.32B | 61.64B | 58.88B | 56.66B | 53.16B |
| Net Income | 24.19B | 19.93B | 19.83B | 18.85B | 15.67B |
Balance Sheet | |||||
| Total Assets | 346.93B | 312.44B | 273.71B | 246.32B | 231.81B |
| Cash, Cash Equivalents and Short-Term Investments | 38.40B | 32.53B | 45.47B | 42.47B | 47.39B |
| Total Debt | 35.57B | 64.21B | 56.42B | 50.47B | 51.12B |
| Total Liabilities | 187.46B | 170.35B | 146.68B | 126.89B | 127.18B |
| Stockholders Equity | 158.01B | 140.68B | 125.75B | 118.24B | 103.53B |
Cash Flow | |||||
| Free Cash Flow | 30.08B | 16.62B | 29.04B | 26.74B | 36.79B |
| Operating Cash Flow | 50.46B | 28.53B | 40.78B | 38.53B | 43.57B |
| Investing Cash Flow | -26.43B | -21.75B | -17.93B | -18.39B | -11.84B |
| Financing Cash Flow | -19.01B | -19.67B | -20.80B | -25.73B | -27.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥535.61B | 21.54 | 15.67% | 1.31% | 9.02% | 21.15% | |
73 Outperform | ¥10.18T | 18.12 | ― | 3.99% | 7.55% | 3.27% | |
69 Neutral | ¥9.97T | 14.15 | 13.75% | 2.85% | 4.05% | 13.53% | |
66 Neutral | ¥16.88B | 50.13 | ― | 1.01% | 14.48% | -12.25% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
57 Neutral | ¥12.61T | 11.39 | 11.22% | 3.36% | 5.14% | 5.49% | |
56 Neutral | ¥318.69B | 17.98 | 17.97% | 1.36% | 5.57% | 31.99% |